Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalon...
Guardado en:
Autores principales: | Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli, Marc Miravitlles |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease
por: Alexa Núñez, et al.
Publicado: (2021) -
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
por: Sandeep Bansal, et al.
Publicado: (2021) -
Mepolizumab and COPD in Real Life
por: Fernando Revuelta-Salgado, et al.
Publicado: (2022) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Jafar Aljazeeri, et al.
Publicado: (2021) -
Towards precision in defining COPD exacerbations
por: Christine R. Jenkins
Publicado: (2021)